A detailed history of Alera Investment Advisors, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 10,868 shares of TERN stock, worth $63,686. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,868
Previous 10,192 6.63%
Holding current value
$63,686
Previous $69,000 30.43%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $4,387 - $7,300
676 Added 6.63%
10,868 $90,000
Q2 2024

Aug 13, 2024

BUY
$4.54 - $8.2 $46,271 - $83,574
10,192 New
10,192 $69,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Alera Investment Advisors, LLC Portfolio

Follow Alera Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.